Galderma SA - Strategic SWOT Analysis Review

November 2021 | 32 pages | ID: G48F7D14F59EN
GlobalData

Abstracts

Galderma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Galderma SA (Galderma) is a pharmaceutical company that develops and markets medical and consumer skin health products. Galderma provides prescription drugs and aesthetic solutions for the treatment of various skin conditions such as acne, rosacea, psoriasis and steroid-responsive dermatoses, nail mycosis, pigmentary disorders, skin cancer, atopic dermatitis and sun protection among others. Its major brands include Epiduo, Differin, Oracea, Loceryl, Metvix, Azzalure/Dysport, Mirvaso, Soolantra, Restylane, Cetaphil and Emervel. The company has its research and development centers and manufacturing sites in Asia-Pacific, the Middle East, Europe, Africa, North and Latin America. Galderma is headquartered in La Tour-de-Peilz, Vaud, Switzerland.

Galderma SA Key Recent Developments

Sep 28,2021: Galderma to unveil ground-breaking data from across its leading dermatology portfolio and showcase major update for sensitive skincare brand CETAPHIL at the 2021 EADV Congress
Sep 09,2021: Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE EYELIGHT at AMWC 2021
Jun 11,2021: Alluzience the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Galderma SA - Key Facts
Galderma SA - Key Employees
Galderma SA - Key Employee Biographies
Galderma SA - Major Products and Services
Galderma SA - History
Galderma SA - Company Statement
Galderma SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Galderma SA - Business Description
Galderma SA - SWOT Analysis
SWOT Analysis - Overview
Galderma SA - Strengths
Galderma SA - Weaknesses
Galderma SA - Opportunities
Galderma SA - Threats
Galderma SA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Galderma SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Galderma SA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 28, 2021: Galderma to unveil ground-breaking data from across its leading dermatology portfolio and showcase major update for sensitive skincare brand CETAPHIL at the 2021 EADV Congress
Sep 09, 2021: Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE EYELIGHT at AMWC 2021
Jun 11, 2021: Alluzience the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Galderma SA, Key Facts
Galderma SA, Key Employees
Galderma SA, Key Employee Biographies
Galderma SA, Major Products and Services
Galderma SA, History
Galderma SA, Subsidiaries
Galderma SA, Key Competitors
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Galderma SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Galderma SA, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Galderma SA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021